Cargando…

Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI

Improved markers for the progression of Parkinson's disease (PD) are required. Previous work has proven that iron dependent MRI scans can detect the largest Nigrosome (N1) within the substantia nigra (SN) pars compacta and changes in PD. Histopathological studies have shown that N1 is particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Stefan Theodor, Mougin, Olivier, Xing, Yue, Blazejewska, Anna, Bajaj, Nin, Auer, Dorothee P., Gowland, Penny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986169/
https://www.ncbi.nlm.nih.gov/pubmed/29872633
http://dx.doi.org/10.1016/j.nicl.2018.05.027
_version_ 1783328883955728384
author Schwarz, Stefan Theodor
Mougin, Olivier
Xing, Yue
Blazejewska, Anna
Bajaj, Nin
Auer, Dorothee P.
Gowland, Penny
author_facet Schwarz, Stefan Theodor
Mougin, Olivier
Xing, Yue
Blazejewska, Anna
Bajaj, Nin
Auer, Dorothee P.
Gowland, Penny
author_sort Schwarz, Stefan Theodor
collection PubMed
description Improved markers for the progression of Parkinson's disease (PD) are required. Previous work has proven that iron dependent MRI scans can detect the largest Nigrosome (N1) within the substantia nigra (SN) pars compacta and changes in PD. Histopathological studies have shown that N1 is particularly affected in early PD whereas the other nigrosomes (N2–N5) and the surrounding iron-rich SN are affected later. In this study we aimed to determine whether MRI can detect the smaller nigrosomes (N2–N5) and whether graded signal alterations can be detected on T2*-weighted MRI at different disease stages consistent with histopathological changes. An observational prospective study was performed within the research imaging centre at the University of Nottingham, UK. Altogether 26 individuals with confirmed PD (median Hoehn&Yahr stage = 1, Unified PD Rating Scale [UPDRS] = 12.5) and 15 healthy controls participated. High resolution T2*weighted 7T MRI of the brain was performed and visibility of N1-N5 within the SN was qualitatively rated. Normalised T2*weighted signal intensities in manually segmented N1–N5 regions and iron-rich SN were calculated. We performed group comparisons and correlations with severity based on UPDRS. Qualitative measures were a nigrosome visibility score and a confidence score for identification. Quantitative measures were T2*weighted contrast of N1–5 and iron-rich SN relative to white matter. We found that visual assessment of the SN for N1–N5 revealed normal range visibility scores in 14 of 15 controls. N1 was identified with the highest confidence and visibility was in abnormal range in all 26 PD patients. The other nigrosomes were less well visible and less confidently identified. There was a larger PD induced signal reduction in all nigrosomes than in the iron-rich SN (median signal difference N1–5 PD compared to controls: 19.4% [IQR = 24%], iron-rich SN 11% [IQR = 24%, p = 0.017]). The largest PD induced signal reduction was in N1: 37.2% [IQR = 19%] which inversely correlated with UPDRS in PD (R(2) = 0.19). All nigrosomes can be detected using 7T MRI, and PD induced T2*weighted signal reduction was greatest in the nigrosomes (especially N1). The graded T2*weighted signal alterations in the nigrosomes match previously described differential histopathological effects of PD. N1 was identified with the highest confidence and T2*weighted signal in N1 correlated with UPDRS confirming N1 as the most promising SN marker of PD pathology.
format Online
Article
Text
id pubmed-5986169
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59861692018-06-05 Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI Schwarz, Stefan Theodor Mougin, Olivier Xing, Yue Blazejewska, Anna Bajaj, Nin Auer, Dorothee P. Gowland, Penny Neuroimage Clin Regular Article Improved markers for the progression of Parkinson's disease (PD) are required. Previous work has proven that iron dependent MRI scans can detect the largest Nigrosome (N1) within the substantia nigra (SN) pars compacta and changes in PD. Histopathological studies have shown that N1 is particularly affected in early PD whereas the other nigrosomes (N2–N5) and the surrounding iron-rich SN are affected later. In this study we aimed to determine whether MRI can detect the smaller nigrosomes (N2–N5) and whether graded signal alterations can be detected on T2*-weighted MRI at different disease stages consistent with histopathological changes. An observational prospective study was performed within the research imaging centre at the University of Nottingham, UK. Altogether 26 individuals with confirmed PD (median Hoehn&Yahr stage = 1, Unified PD Rating Scale [UPDRS] = 12.5) and 15 healthy controls participated. High resolution T2*weighted 7T MRI of the brain was performed and visibility of N1-N5 within the SN was qualitatively rated. Normalised T2*weighted signal intensities in manually segmented N1–N5 regions and iron-rich SN were calculated. We performed group comparisons and correlations with severity based on UPDRS. Qualitative measures were a nigrosome visibility score and a confidence score for identification. Quantitative measures were T2*weighted contrast of N1–5 and iron-rich SN relative to white matter. We found that visual assessment of the SN for N1–N5 revealed normal range visibility scores in 14 of 15 controls. N1 was identified with the highest confidence and visibility was in abnormal range in all 26 PD patients. The other nigrosomes were less well visible and less confidently identified. There was a larger PD induced signal reduction in all nigrosomes than in the iron-rich SN (median signal difference N1–5 PD compared to controls: 19.4% [IQR = 24%], iron-rich SN 11% [IQR = 24%, p = 0.017]). The largest PD induced signal reduction was in N1: 37.2% [IQR = 19%] which inversely correlated with UPDRS in PD (R(2) = 0.19). All nigrosomes can be detected using 7T MRI, and PD induced T2*weighted signal reduction was greatest in the nigrosomes (especially N1). The graded T2*weighted signal alterations in the nigrosomes match previously described differential histopathological effects of PD. N1 was identified with the highest confidence and T2*weighted signal in N1 correlated with UPDRS confirming N1 as the most promising SN marker of PD pathology. Elsevier 2018-05-24 /pmc/articles/PMC5986169/ /pubmed/29872633 http://dx.doi.org/10.1016/j.nicl.2018.05.027 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Regular Article
Schwarz, Stefan Theodor
Mougin, Olivier
Xing, Yue
Blazejewska, Anna
Bajaj, Nin
Auer, Dorothee P.
Gowland, Penny
Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title_full Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title_fullStr Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title_full_unstemmed Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title_short Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
title_sort parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using t2* weighted 7t mri
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986169/
https://www.ncbi.nlm.nih.gov/pubmed/29872633
http://dx.doi.org/10.1016/j.nicl.2018.05.027
work_keys_str_mv AT schwarzstefantheodor parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT mouginolivier parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT xingyue parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT blazejewskaanna parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT bajajnin parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT auerdorotheep parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri
AT gowlandpenny parkinsonsdiseaserelatedsignalchangeinthenigrosomes15andthesubstantianigrausingt2weighted7tmri